Literature DB >> 21603690

Structure, electronic properties and catalytic behaviour of an activity-enhancing CYP102A1 (P450(BM3)) variant.

Christopher J C Whitehouse1, Wen Yang, Jake A Yorke, Henry G Tufton, Lydia C I Ogilvie, Stephen G Bell, Weihong Zhou, Mark Bartlam, Zihe Rao, Luet-Lok Wong.   

Abstract

The substrate-free crystal structure of a five-mutation directed evolution variant of CYP102A1 (P450(BM3)) with generic activity-enhancing properties ("KT2") has been determined to 1.9-Å resolution. There is a close resemblance to substrate-bound structures of the wild-type enzyme (WT). The disruption of two salt bridges that link the G- and I-helices in WT causes conformational changes that break several hydrogen bonds and reduce the angle of the kink in the I-helix where dioxygen activation is thought to take place. The side-chain of a key active site residue, Phe87, is rotated in one molecule of the asymmetric unit, and the side-chains of Phe158 and Phe261 cascade into the orientations found in fatty-acid-bound forms of the enzyme. The iron is out of the porphyrin plane, towards the proximal cysteine. Unusually, the axial water ligand to the haem iron is not hydrogen-bonded to Ala264. The first electron transfer from the reductase domain to the haem domain of substrate-free KT2 is almost as fast as in palmitate-bound WT even though the reduction potential of the haem domain is only slightly more oxidising than that of substrate-free WT. However, NADPH is turned over slowly in the absence of substrate, so the catalytic cycle is gated by a step subsequent to the first electron transfer-a contrast to WT. Propylbenzene binding slightly raises the first electron transfer rate in WT but not in KT2. It is proposed that the generic rate accelerating properties of KT2 arise from the substrate-free form being in a catalytically ready conformation, such that substrate-induced changes to the structure play a less significant role in promoting the first electron transfer than in WT.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21603690     DOI: 10.1039/c1dt10098j

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  8 in total

1.  Insights into an efficient light-driven hybrid P450 BM3 enzyme from crystallographic, spectroscopic and biochemical studies.

Authors:  Jessica Spradlin; Diana Lee; Sruthi Mahadevan; Mavish Mahomed; Lawrence Tang; Quan Lam; Alexander Colbert; Oliver S Shafaat; David Goodin; Marco Kloos; Mallory Kato; Lionel E Cheruzel
Journal:  Biochim Biophys Acta       Date:  2016-09-14

Review 2.  Reactive intermediates in cytochrome p450 catalysis.

Authors:  Courtney M Krest; Elizabeth L Onderko; Timothy H Yosca; Julio C Calixto; Richard F Karp; Jovan Livada; Jonathan Rittle; Michael T Green
Journal:  J Biol Chem       Date:  2013-04-30       Impact factor: 5.157

Review 3.  A novel type of allosteric regulation: functional cooperativity in monomeric proteins.

Authors:  Ilia G Denisov; Stephen G Sligar
Journal:  Arch Biochem Biophys       Date:  2012-01-08       Impact factor: 4.013

4.  Chain length-dependent cooperativity in fatty acid binding and oxidation by cytochrome P450BM3 (CYP102A1).

Authors:  Benjamin Rowlatt; Jake A Yorke; Anthony J Strong; Christopher J C Whitehouse; Stephen G Bell; Luet-Lok Wong
Journal:  Protein Cell       Date:  2011-09-09       Impact factor: 14.870

5.  A series of hybrid P450 BM3 enzymes with different catalytic activity in the light-initiated hydroxylation of lauric acid.

Authors:  Ngoc-Han Tran; Ngoc Huynh; Garrett Chavez; Angelina Nguyen; Sudharsan Dwaraknath; Thien-Anh Nguyen; Maxine Nguyen; Lionel Cheruzel
Journal:  J Inorg Biochem       Date:  2012-06-02       Impact factor: 4.155

6.  Molecular Determinants of Substrate Affinity and Enzyme Activity of a Cytochrome P450BM3 Variant.

Authors:  Inacrist Geronimo; Catherine A Denning; David K Heidary; Edith C Glazer; Christina M Payne
Journal:  Biophys J       Date:  2018-08-27       Impact factor: 4.033

Review 7.  A Promiscuous Bacterial P450: The Unparalleled Diversity of BM3 in Pharmaceutical Metabolism.

Authors:  Sian Thistlethwaite; Laura N Jeffreys; Hazel M Girvan; Kirsty J McLean; Andrew W Munro
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923

8.  Engineering of CYP153A33 With Enhanced Ratio of Hydroxylation to Overoxidation Activity in Whole-Cell Biotransformation of Medium-Chain 1-Alkanols.

Authors:  Hyuna Park; Doyeong Bak; Wooyoung Jeon; Minjung Jang; Jung-Oh Ahn; Kwon-Young Choi
Journal:  Front Bioeng Biotechnol       Date:  2022-01-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.